Immediate Impact
9 from Science/Nature 69 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Works of Marcella Petrone being referenced
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of A sian descent with or without type 2 diabetes
2021
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marcella Petrone | 356 | 442 | 194 | 26 | 846 | |
| Torsten Haack | 286 | 354 | 156 | 27 | 653 | |
| Diane M. Hargrove | 342 | 222 | 169 | 29 | 782 | |
| K. Steiner | 286 | 219 | 231 | 36 | 892 | |
| Martin J. Procter | 372 | 333 | 331 | 15 | 871 | |
| William J. Zavadoski | 282 | 202 | 137 | 17 | 688 | |
| Sachiya Ikeda | 419 | 398 | 256 | 17 | 923 | |
| Janice C. Parker | 340 | 259 | 255 | 23 | 680 | |
| Chang Yell Shin | 353 | 166 | 80 | 44 | 818 | |
| Maria Helena Catelli de Carvalho | 359 | 221 | 105 | 29 | 961 | |
| Anne‐Dominique Lajoix | 347 | 251 | 278 | 38 | 910 |
All Works
Loading papers...